Retraction of: Scientific Reports https://doi.org/10.1038/s41598-020-80911-z, published online 26 January 2021
Editors have retracted this Article.
An investigation at the Moffitt Cancer Center confirmed that Figures 2a and 6f of this Article contain multiple instances of overlaps representing different experimental conditions. Original data for Figure 2a was no longer available; the original data for Figure 6f was available and corroborated the concerns about the figure content.
Domenico Coppola, Chung S. Yang, and Mokenge P. Malafa did not respond to the correspondence from Editors about the retraction. The Editors were not able to confirm the contact details for Kazim Husain.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Husain, K., Coppola, D., Yang, C.S. et al. Retraction Note: Farnesyl dimethyl chromanol targets colon cancer stem cells and prevents colorectal cancer metastasis. Sci Rep 15, 39181 (2025). https://doi.org/10.1038/s41598-025-27189-1
Published:
Version of record:
DOI: https://doi.org/10.1038/s41598-025-27189-1
